Search

everythinglearnresearchcommunity

for

Search:↓

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Hair loss increases with age; alcohol raises risk, more female partners lowers it.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Estrogen therapy can reduce skin aging but has cancer risks.

Laser hair removal effectiveness depends on targeting hair structures without harming the skin, and improvements require more research and expert collaboration.

Too much androgen can cause hair loss; finasteride may help.

Masculine facial features may not reliably indicate heritable health, and more research is needed.

The document recommends using both clinical evaluation and various measurement methods to assess skin greasiness, considering factors like temperature and hormones.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Antibiotics can reduce acne but may lead to resistant bacteria, and understanding the skin's bacteria is important for treatment.

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.

The document concludes that understanding hair structure is key to diagnosing hair abnormalities and recommends gentle hair care for management.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

The BASP classification is a detailed and accurate way to categorize hair loss in both men and women.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

The research found that Atypical Progeroid Syndrome has unique symptoms and is not caused by the buildup of a certain mutant protein.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Lowering testosterone speeds up wound healing in male mice.

The document concludes that understanding the sebaceous gland's development and function is key to addressing related skin diseases and aging effects.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.